Many pharmaceutical and biopharma companies have announced bold Lean Six Sigma programs, only to have them quietly disappear a few years later. Sustainable results offer huge payoffs, but require management support, corporate commitment and nurturing from the R&D stage through manufacturing. Here, companies that are in Lean Six Sigma for the long haul share best practices and the financial results that you can expect. They also address how to get management buy-in for programs that will withstand the test of time.